Industry Insights Seminar Series
The Industry Insights Seminar Series is hosted by the Business Partnerships Office and sponsored by the BioEscalator.
- First Tuesday of every month
- 12.00 -1.00 pm
- In person and via Zoom
- Networking & 1:1 meeting opportunities
Selected industry speakers provide seminars that are scientific in nature, across a range of medical or health topics. Speakers are encouraged to bring along colleagues providing the opportunity for Oxford scientists to attend a scientific seminar of interest and also to network with industry scientists. One to one meetings can be facilitated upon request. Seminars are suitable for all scientists with some knowledge or interest in each topic area, from PhD students to PIs. Although mostly aimed at an academic audience, those located in the BioEscalator and Wood Centre, as well as local spinouts, are welcome to attend.
17 May 2022: Physical Modelling and Machine Intelligence for Accelerated Discovery
Company: IBM
Presenter: Jason Crain, IBM Research
IBM Research, are inventing what's next in AI, quantum computing, and hybrid cloud to shape the world ahead.
They’re discovering the new materials that will become the next generation of computer chips; They’re building bias-free AI that can take the burden out of healthcare decisions; They’re designing a hybrid-cloud platform that essentially operates as the world’s computer. They’re moving quantum computing from a theoretical concept to machines that are redefining industry and society.
14 June 2022
Company: Psious
Presenter: Iris-Valerie Stracke (Head of Clinical and Regulatory Affairs)
Psious' virtual reality tool can be used by mental health professionals in CBT, exposure therapy and other interventions allowing them to have full control over the parameters.
Through close collaboration with leading public and private institutions, Psious are proud to advance research and promote evidence-based care for better mental-health, globally.
6 September 2022
Company: Natural Cycles
Presenter: Jack Pearson (Medical Affairs Manager)
Natural Cycles is an app powered by an algorithm that determines fertility status based on basal body temperature. Measure with the NC° thermometer, enter into the app, and let the algorithm do the work.
Register for the Natural Cycles talk
Changes to the event format
These events were in person at the BioEscalator, however, since Covid-19, these seminars have become a hybrid event of in person and virtual.
Contact
Please contact either Sheena Lee if you have any questions.
If you have an industry partner you would like to invite to speak, please contact Sheena Lee.
Previous Talks
5 APRIL 2022: GENE THERAPY – COMING OF AGE
Company: Oxford Biomedica
Presenter: Yatish Lad (Vice President, Head of Early Development)
1 March 2022: Combining Robotics and AI: The Emergence of Data-Driven Drug Discovery
Company: Arctoris
Presenter: Martin-Immanuel Bittner (Co-founder and CEO)
1 February 2022: Bridgebio Pharma: Turning Translational Academic Research into Medicines for Patients with Genetic Diseases
Company BridgeBio
Presenter: Anna Hakes, PhD
7 December 2021: Target discovery opportunities using machine learning on longitudinal patient journeys
Company: Novo Nordisk Research Centre Oxford
Presenter: Ramneek Gupta-Head of Computational Biology
2nd November 2021: Translational Fellowships: Perspectives from a BMS mentor and 5 Oxford-BMS Fellows
Company: Bristol Myers Squibb
Presenter: Professor Anjan Thakurta
5th October 2021: Humanising drugs
Company: Vertex
Presenter: David Price
7th September: Development of Novel Medicines Using High Resolution, Native Mass Spectrometry of Intact Protein Assemblies
Company: OMass
Presenter: Katharina Duerr
July 2021: Tumour Re-Engineering
Company: PsiOxus
Presenter: Manuela Zonca - Senior Research Scientist PsiOxus
4th May 2021: Improving Drug Delivery in Ophthalmology
Company: Visusnano
Presenter: Joanna Gould - CEO, VisusNano
Video: https://youtu.be/5p9jYcd87Nw
6th April 2021: Accelerating Covid-19 Antibody Discovery through Industry-Academia Consortium
Company: BioIndustry Association (BIA)
Presenter: Jane Osbourn OBE, CSO Alchemab and Paul Kellam VP infectious diseases and vaccines, Kymab.
2nd March 2021: Transforming the Path for Equitable Access to Rapid Diagnostics for Epidemics
Company: Mologic
Presenter: Joe Fitchett - Medical Director
2 February 2021: Targeting the Aryl Hyrdrocarbon Receptor (AHR) as a Novel Immunotherapy for the Treatment of Cancer
Company: Bayer AG
Presenter: Dr Ilona Gutcher - Group Leader Oncology
5 January 2021: Exosome-Based Therapies for the Treatment of Rare Genetic Diseases
Company: Evox Therapeutics
Presenter: David Lowe - Vice President, Research
6 October 2020: Maintaining Human Livers Outside Of The Body: From Advances In Transplant Medicine To Developing Liver Nash Therapies
Company: Ochre Bio & OrganOx
Presenters: Quin Wills & Jack O'Meara, CSO and CEO Ochre Bio and Andy Self, Commercial Director at OrganOx
1 September 2020: Biotherapeutic Medicines From Botulinum Neurotoxins
Company: Ipsen
Presenter: Matthew Beard
7 July 2020: Translational Science & Medicine In Industry
Company: Janssen R&D
Presenter: Luke Devey, VP Translational science
2 June 2020: A Multi-Omics Approach For Type 2 Diabetes Target Discovery: Identification And Characterisation Of Disease-Specific Small Open Reading Frame Encoded Peptides
Company: Novo Nordisk
Presenter: Dr. Bill Haynes, Site Head and Vice President, Novo Nordisk Research Centre Oxford
3 March 2020: Deep Learning Based Image Enhancement In Positron Emission Tomography
Company: GE Healthcare
Presenter: Dr Abolfazl Mehranian - Imaging Scientist
4 February 2020: What Disease? – Do We Have The Right Approach To Disease Classification And How This Should Impact Our Approach To Treatment
Company: Sensyne Health
Presenter: Dr Rabia Khan - Chief of Translational Medicine
7 January 2020: Utility Of Non-Invasive Image Derived Biomarkers To Characterise Health And Disease: Advances Towards Personalised Medicine
Company: Perspectum Diagnostics Ltd
Presenter: Dr Andrea Dennis - Head of Biomarker Sciences
4 December 2019: When Less Is More - A New Twist To GalNAc-Conjugated siRNA For Treatment Of Liver-Related Disorders
Company: Silence Therapeutics
Presenter: Dr Marie Wikstrom Lindholm - VP Head of Technology Innovation